Related Experiment Video
Updated: Apr 16, 2026

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks
Published on: June 26, 2020
[Hepatitis C virus infection and hemodialysis: update 2014]
Insights
Hepatitis C virus (HCV) is common in hemodialysis (HD) patients, impacting survival. New direct-acting antivirals (DAAs) offer hope, but interferon beta
Area of Science:
- Hepatology and Virology
- Nephrology and Dialysis Medicine
Context:
- Hepatitis C virus (HCV) infection is highly prevalent in hemodialysis (HD) patients.
- HCV infection is a significant risk factor for reduced survival rates in HD populations.
Purpose:
- To explore the understanding of HCV natural history in HD patients.
- To evaluate the potential benefits of interferon beta in combination with direct-acting antivirals (DAAs) for HCV elimination in HD patients.
Summary:
- Direct-acting antivirals (DAAs) have shown high efficacy in clearing HCV infection.
- HD patients face unique challenges in HCV treatment adherence and tolerance.
- Interferon beta's favorable safety profile warrants consideration alongside DAAs for HCV eradication in HD patients.
Impact:
- Improved therapeutic strategies for HCV in hemodialysis patients.
- Enhanced survival and quality of life for HD patients with HCV.
- Further research into combination therapies for HCV elimination in this vulnerable group.
Abstract:
Since hepatitis C virus (HCV) infection is much common among hemodialysis (HD) patients, the natural history of HCV is not sufficiently understood. It has been reported that HCV infection is one of the major risk factors for the lower survival among HD patients. Recent progression of the therapy involving direct acting antiviral (DAA) can eliminate HCV infection in almost HCV infected patients, resulting HD patients should also get this benefit. Though HD patients have many restricted factors for accepting anti HCV therapy, the significance of clinical usefulness of interferon beta that has less adverse effect should be more deeply considered with newly developed DAAs for eliminating HCV infected HD patients.
Related Concept Videos
Hepatitis
Hemodialysis II: Procedure and Complications
Hemodialysis I: Introduction
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
Hemodialysis III: Nursing Management
Continuous Renal Replacement Therapy

